S9562 Ht injection palivizumab/ab diem
Also known as: home palivizumab, home monoclonal antibody, home mAb infusion
Home infusion therapy administration of palivizumab or other monoclonal antibody injection on a per-diem basis.
In Plain Language
home antibody injection; home immune protein treatment
Clinical Context
Provides home administration of palivizumab for respiratory syncytial virus prophylaxis in high-risk infants or other monoclonal antibody therapies.
RVU Information
CPT S9562 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
S-codes are used by private payers (not Medicare) for services without a standard CPT or HCPCS code. Coverage varies significantly between insurers. Verify payer acceptance before billing and document medical necessity thoroughly.
Specialties
Frequently Asked Questions
What is CPT code S9562?
CPT S9562 (Ht injection palivizumab/ab diem) is a S Codes code. Home infusion therapy administration of palivizumab or other monoclonal antibody injection on a per-diem basis.
Is S9562 covered by insurance?
S9562 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Provides home administration of palivizumab for respiratory syncytial virus prophylaxis in high-risk infants or other monoclonal antibody therapies.
When is CPT S9562 used?
Provides home administration of palivizumab for respiratory syncytial virus prophylaxis in high-risk infants or other monoclonal antibody therapies.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.